Generating Influenza Pseudotyped Viral Particles
Corresponding Organization :
Other organizations : Brunel University of London, Vellore Institute of Technology University, King Faisal Specialist Hospital & Research Centre, King Saud University, University of Oxford
Protocol cited in 2 other protocols
Variable analysis
- IAV subtypes used in this study, including the pH1N1 (A/England/2009) and H3N2 (A/HK/1999)
- Plasmids used for the production of H1N1 and H3N2 pseudo-typed viral particles (pHIV-Luciferase, psPAX2, and Vesicular Stomatitis Virus (VSV-G))
- Commercially obtained plasmids (pcDNA3.1-swineH1-flag, pcDNA3.1-swine N1-flag, and pCDNA H3)
- PI.18-N2 [N2 from A/Texas/50/2012/(H3N2)] plasmid
- Measured outcomes (not explicitly mentioned)
- Anti-influenza antibodies used (polyclonal anti-influenza Virus H3 HA, A/Hong Kong/1/1968 and monoclonal anti-influenza virus H1 HA, A/California /04/2009)
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!